Abstract:Background An adverse drug event (ADE) is commonly defined as “an injury resulting from medical intervention related to a drug.” Providing information related to ADEs and alerting caregivers at the point of care can reduce the risk of prescription and diagnostic errors and improve health outcomes. ADEs captured in structured data in electronic health records (EHRs) as either coded problems or allergies are often incomplete, leading to underreporting. Therefore, it is important to develop capabilities to process unstructured EHR data in the form of clinical notes, which contain a richer documentation of a patient’s ADE. Several natural language processing (NLP) systems have been proposed to automatically extract information related to ADEs. However, the results from these systems showed that significant improvement is still required for the automatic extraction of ADEs from clinical notes. Objective This study aims to improve the automatic extraction of ADEs and related information such as drugs, their attributes, and reason for administration from the clinical notes of patients. Methods This research was conducted using discharge summaries from the Medical Information Mart for Intensive Care III (MIMIC-III) database obtained through the 2018 National NLP Clinical Challenges (n2c2) annotated with drugs, drug attributes (ie, strength, form, frequency, route, dosage, duration), ADEs, reasons, and relations between drugs and other entities. We developed a deep learning–based system for extracting these drug-centric concepts and relations simultaneously using a joint method enhanced with contextualized embeddings, a position-attention mechanism, and knowledge representations. The joint method generated different sentence representations for each drug, which were then used to extract related concepts and relations simultaneously. Contextualized representations trained on the MIMIC-III database were used to capture context-sensitive meanings of words. The position-attention mechanism amplified the benefits of the joint method by generating sentence representations that capture long-distance relations. Knowledge representations were obtained from graph embeddings created using the US Food and Drug Administration Adverse Event Reporting System database to improve relation extraction, especially when contextual clues were insufficient. Results Our system achieved new state-of-the-art results on the n2c2 data set, with significant improvements in recognizing crucial drug−reason (F1=0.650 versus F1=0.579) and drug−ADE (F1=0.490 versus F1=0.476) relations. Conclusions This study presents a system for extracting drug-centric concepts and relations that outperformed current state-of-the-art results and shows that contextualized embeddings, position-attention mechanisms, and knowledge graph embeddings effectively improve deep learning–based concepts and relation extraction. This study demonstrates the potential for deep learning–based methods to help extract real-world evidence from unstructured patient data for drug safety surveillance.

Discovering adverse drug events combining spontaneous reports with electronic medical records: a case study of conventional DMARDs and biologics for rheumatoid arthritis

Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

Identification of Adverse Drug Events in Chinese Clinical Narrative Text

Detecting Adverse Drug Event Signals from a Clinical CaseBase.

Study of Serious Adverse Drug Reactions Using FDA-approved Drug Labeling and MedDRA

A method for systematic discovery of adverse drug events from clinical notes.

Leveraging Food and Drug Administration Adverse Event Reports for the Automated Monitoring of Electronic Health Records in a Pediatric Hospital.

Application of Association Rules Analysis in Mining Adverse Drug Reaction Signals

Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions

Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies

Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data

Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data

Mining Adverse Drug Reactions from Unstructured Mediums at Scale

AB0501 Adverse Events with Treatment Regimens of Rheumatoid Arthritis (RA) Reported by Patients Applying Smart System of Disease Management (SSDM) Mobiles Tools: a Cohort Study of Ra Patients in China

Investigating the Detection of Adverse Drug Events in a UK General Practice Electronic Health-Care Database

Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records

Extraction of Information Related to Drug Safety Surveillance From Electronic Health Record Notes: Joint Modeling of Entities and Relations Using Knowledge-Aware Neural Attentive Models

SAT0119 CREATE RISK PREDICTION MODELING AND DRUG WITHDRAW ROAD MAP THROUGH PATTERN EXTRACTION AND DATA MINING: A MASTER ALGORITHM DEVELOPMENT FROM THE SMART SYSTEM OF DISEASE MANAGEMENT (SSDM)

Extraction of Information Related to Drug Safety Surveillance From Electronic Health Record Notes: Joint Modeling of Entities and Relations Using Knowledge-Aware Neural Attentive Models (Preprint)

Extracting adverse drug events from clinical Notes: A systematic review of approaches used

AB0322 Develop an master algorithm for drug withdraw strategy in reduction of adverse events with combination therapy- a machine learning model from the smart system of disease management (SSDM)